$42.45
0.671.6%
Last update: Nov 6, 1:41 PM
Teva Pharmaceutical Industries Ltd
TEVANYSE
The average analyst price target for Teva Pharmaceutical Indus is $41.50, 2.2% below the current price. Of 13 analysts, 13 rate it Buy. Targets range from $11 to $57. The latest change came on Nov 5, 2026, when Leerink Partners raised its price target on Teva Pharmaceutical Indus from $45 to $52 and kept an Outperform rating.
Price Target Range — 13 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
